|
|
|
|
| LEADER |
01000caa a22002652c 4500 |
| 001 |
NLM323102492 |
| 003 |
DE-627 |
| 005 |
20250301064558.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
231225s2021 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1016/j.molliq.2021.115934
|2 doi
|
| 028 |
5 |
2 |
|a pubmed25n1076.xml
|
| 035 |
|
|
|a (DE-627)NLM323102492
|
| 035 |
|
|
|a (NLM)33753950
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Wani, Tanveer A
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Binding and drug displacement study of colchicine and bovine serum albumin in presence of azithromycin using multispectroscopic techniques and molecular dynamic simulation
|
| 264 |
|
1 |
|c 2021
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Date Revised 03.10.2024
|
| 500 |
|
|
|a published: Print-Electronic
|
| 500 |
|
|
|a Citation Status PubMed-not-MEDLINE
|
| 520 |
|
|
|a © 2021 Elsevier B.V. All rights reserved.
|
| 520 |
|
|
|a The binding and displacement interaction of colchicine and azithromycin to the model transport protein bovine serum albumin (BSA) was evaluated in this study. Azithromycin, a macrolide antibiotic, has antiviral properties and hence, has been used concomitantly with hydroxychloroquine against SARS-CoV-2. Colchicine, a natural plant product is used to treat and prevent acute gout flares. Some macrolide antibiotics are reported to have fatal drug-drug interactions with colchicine. The displacement interaction between colchicine and azithromycin on binding to BSA was evaluated using spectroscopic techniques, molecular docking and molecular dynamic simulation studies. The binding constant recorded for the binary system BSA-colchicine was 7.44 × 104 whereas, the binding constant for the ternary system BSA-colchicine in presence of azithromycin was 7.38 × 104 and were similar. Azithromycin didn't bind to BSA neither did it interfere in binding of colchicine. The results from molecular docking studies also led to a similar conclusion that azithromycin didn't interfere in the binding of colchicine to BSA. These findings are important since there is possibility of serious adverse event with co-administration of colchicine and azithromycin in patients with underlying gouty arthritis and these patients need to be continuously monitored for colchicine toxicity
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a Azithromycin
|
| 650 |
|
4 |
|a Binding interaction
|
| 650 |
|
4 |
|a Bovine serum albumin
|
| 650 |
|
4 |
|a Colchicine
|
| 650 |
|
4 |
|a Fluorescence quenching
|
| 700 |
1 |
|
|a Bakheit, Ahmed H
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Al-Majed, Abdulrahman A
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Altwaijry, Nojood
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Baquaysh, Anwar
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Aljuraisy, Ashwaq
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Zargar, Seema
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Journal of molecular liquids
|d 1998
|g 333(2021) vom: 01. Juli, Seite 115934
|w (DE-627)NLM098180800
|x 0167-7322
|7 nnas
|
| 773 |
1 |
8 |
|g volume:333
|g year:2021
|g day:01
|g month:07
|g pages:115934
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1016/j.molliq.2021.115934
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 333
|j 2021
|b 01
|c 07
|h 115934
|